Method for producing cell-free supernatants with enhanced antimicrobial activity through co-cultivation of probiotic lactobacillus strains

Co-cultivation of selected lactobacilli strains enhances the antimicrobial activity of cell-free supernatants, addressing the inefficiencies of existing methods by producing effective bioprotectors for plant products against opportunistic pathogens.

UA164625UActive Publication Date: 2026-10-21LTD LIABILITY CORP EDIENS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
UA202600673U
Authority / Receiving Office
UA · UA
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2026-02-10
Publication Date
2026-10-21
Estimated Expiration
2036-02-10

AI Technical Summary

Technical Problem

Existing methods for obtaining cell-free supernatants from probiotic strains of lactobacilli do not effectively harness synergistic combinations to enhance antimicrobial activity against opportunistic pathogens, posing a risk to human health through contaminated fresh plant products.

Method used

A method involving co-cultivation of specific probiotic strains of lactobacilli in a sterile MRS broth medium at 37°C for 24 hours, followed by centrifugation and filtration, to produce cell-free supernatants with enhanced antimicrobial activity against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens.

Benefits of technology

The co-cultivation method results in cell-free supernatants with increased viable cell counts and antimicrobial activity, demonstrating zones of inhibition up to 26.67 mm against tested pathogens, exceeding monoculture activities.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

Method for producing cell-free supernatants with enhanced antimicrobial activity through co-cultivation of probiotic Lactobacillus strains involves cultivating probiotic Lactobacillus strains in a liquid culture medium, followed by the separation of the cell mass. Co-cultivation of at least two probiotic Lactobacillus spp. strains is performed in a sterile MRS broth medium at 37°C for 24 hours. Wherein, 10 ml of medium is inoculated with 50 μl of suspensions of each strain at a concentration of 10⁸ CFU / ml. The culture fluid is centrifuged for 15 minutes at 2,500 g. The resulting fluid is filtered through a membrane filter with a pore size of 0.22 µm.
Need to check novelty before this filing date? Find Prior Art

Description

The utility model belongs to the field of food biotechnology, in particular to methods of obtaining cell-free supernatants with enhanced antimicrobial activity by co-cultivation probiotic strains of lactobacilli for biocontrol of opportunistic pathogens (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens). The resulting supernatants can be used to extend the shelf life of plant-based foods origin. Fresh vegetables and fruits are a source of nutrients and bioactive compounds, including fiber, vitamins, minerals, phenolic substances and peptides that play an important role in maintaining a healthy human nutrition [1]. However, consumption of fresh plant products contaminated with opportunistic pathogenic microorganisms, is dangerous to human health, as it can lead to development of foodborne infections and outbreaks of poisoning [2]. Probiotic strains of lactic acid bacteria (LAB) are used in the food industry for increasing their resistance to infections and reducing contamination with opportunistic pathogens microorganisms [3-4]. It is known that the antimicrobial effect of MKB is usually realized through production of biologically active metabolites that determine their functional activity. To Such metabolites include organic acids (in particular, lactic, acetic, propionic, etc.), peroxide hydrogen, diacetyl, bacteriocins, exopolysaccharides, vitamins and others [5]. Thanks to this metabolic profile cell-free supernatants obtained from MKB strains exhibit antimicrobial activity against a wide range of microorganisms [6-8]. A method of biocontrol of phytopathogenic bacteria Pseudomonas syringae using bacteriocins (pyocins) produced by Pseudomonas aeruginosa. [9]. Also, there is a known method of protecting plants from the bacterial disease "black leg" using Lactiplantibacillus plantarum combined with autolysate of the bacterium Erwinia carotovora

[10] . A method of obtaining cell-free supernatants by inoculation of microorganisms is known

[11] . of various genera (Aspergillus, Bacillus, Rhodopseudomonas, Candida, Lactobacillus, Pseudomonas, Saccharomyces and Streptococcus) for agricultural applications. However, this method does not revealed the selection of synergistic combinations of probiotic strains capable of increasing antimicrobial activity of cell-free supernatants against opportunistic pathogens. The utility model is based on the task of developing a method for obtaining cell-free supernatants with increased antimicrobial activity by co-cultivation probiotic strains of lactobacilli, which are used as natural bioprotectors of plant products, which ensure a reduction in the level of contamination by opportunistic microorganisms. The problem is solved by the fact that the method of obtaining cell-free supernatants from increased antimicrobial activity through co-cultivation of probiotic strains lactobacilli, which involves the cultivation of probiotic strains of lactobacilli in a liquid nutrient medium medium with subsequent separation of the cell mass, co-cultivation is carried out at least two probiotic strains of Lactobacillus spp. in sterile MRS broth medium at a temperature of 37 C for 24 hours, while 10 ml of medium is inoculated with 50 μl of suspensions of each strain at a concentration of 108 CFU / ml, after which the culture liquid is centrifuged for 15 min at 2500 g, the resulting liquid is filtered through a membrane filter with a pore size of 0.22 μm. Co-cultivation is carried out using combinations of probiotic strains of Lactobacillus spp., selected from the group: Lacticaseibacillus casei IMB 7412+Lactobacillus bulgaricus S6, Lactobacillus bulgaricus A22+Lactobacillus bulgaricus S6, Lactiplantibacillus plantarum A+Lactobacillus bulgaricus S6, Lactiplantibacillus plantarum A+Lactobacillus bulgaricus A22. The strain Lacticaseibacillus casei IMB 7412 is deposited in the State Collection of Microorganisms of the Institute D.K. Zabolotny Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine under registration number IMB B-7412. Other strains of microorganisms (Lactiplantibacillus plantarum A, Lactobacillus bulgaricus A6, Lactobacillus bulgaricus A22, Lactobacillus bulgaricus S6) are stored in the author's collection of the Department of Biotechnology University of Food Technologies (Plovdiv, Bulgaria) and have certificates of conformity Selur Pharma Ltd. (Bulgaria). The technical result provided by the proposed utility model is obtaining cell-free supernatants with increased antimicrobial activity, achieved thanks to synergistic action of metabolites during co-cultivation of probiotic strains. The method is carried out as follows: Take 10 ml of sterile MRS broth medium and inoculate 50 μl of 24-hour suspensions of two probiotic strains of Lactobacillus spp. at a concentration of 108 CFU / ml. Inoculated samples incubated for 24 hours at 37 °C. After incubation, tenfold serial Dilution and plating on MRS-arap to determine cell viability. It has been established that the cultivation of individual pairs of probiotic strains contributes to an increase in the number of viable cells compared to monocultures (Table 1). Table 1 Number of viable cells in monocultures and co-cultures of probiotic strains of lactobacilli Culture Viable cell count, log10 CFU / ml Monoculture 7412 9.46±0.73 A 8.40±0.17 A6 8.01±0.02 A22 8.49±0.20 S6 8.98±0.05 Shared culture 7412+A 9.37±0.54 7412+A6 8.95±0.23 7412+A22 9.73±0.30 7412+S6 8.84±0.06 A+A6 8.65±0.16 A+A22 8.73±0.46 A+S6 8.62±0.15 A6+A22 8.74±0.23 A6+S6 8.97±0.07 A22+S6 8.50±0.17 Note. 7412-Lacticaseibacillus casei; A-Lactiplantibacillus plantarum; A6, A22, S6-Lactobacillus bulgaricus. The most pronounced increase in cell number was observed for the co-culture of Lactobacillus casei IMB 7412+Lactobacillus bulgaricus A22, where the level of viable cells was 9.73±0.30 log10 CFU / ml, which exceeded the indicators of monocultures of Lactobacillus casei IMB 7412 (9.46±0.73 log10 CFU / ml) and Lactobacillus bulgaricus A22 (8.49±0.20 log10 CFU / ml). To obtain cell-free supernatants, the culture fluid is centrifuged for 15 min. at 2500 g. The resulting liquid is filtered through membrane filters with a pore size of 0.22 μm, after which The sterility of the supernatants is checked by plating on MRS-arap. Sterile filtrates used to determine the pH of cell-free supernatants (Table 2). Table 2 The pH value of the cell-free supernatants obtained from monocultures and co-cultures of probiotic strains of lactobacilli Culture supernatant pH Monoculture 7412 3.59±0.03 A 3.72±0.02 A6 3.80±0.01 A22 3.64±0.02 S6 3.48±0.01 Shared culture 7412+A 3.53±0.01 7412+A6 3.51±0.01 7412+A22 3.46±0.02 7412+S6 3.52±0.01 A+A6 3.60±0.04 A+A22 3.68±0.01 A+S6 3.52±0.02 A6+A22 3.62±0.05 A6+S6 3.55±0.04 A22+S6 3.49±0.00 Note. 7412-Lacticaseibacillus casci; A-Lactiplantibacillus plantarum; A6, A22, S6-Lactobacillus bulgaricus. It was found that the lowest pH value was observed in the co-culture supernatant. Lactobacillus casei IMB 7412+Lactobacillus bulgaricus A22 (3.46±0.02), indicating enhanced production of organic acids. The antimicrobial activity of cell-free supernatants was determined by the agar well diffusion method. Mueller-Hinton. 24-hour cultures of microorganisms (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens) at a concentration of 106 CFU / ml. In Wells with a diameter of 8 mm were formed in the agar layer, into which 100 μl of supernatant was added. As a control Sterile MRS broth medium was used. After incubation at 37 °C Within 24 hours, the diameters of growth inhibition zones were determined. Table 3 shows the results of the study of the antimicrobial activity of acellular supernatants obtained from monocultures and co-cultures of probiotic strains of lactobacilli against opportunistic pathogens isolated from lettuce leaves. Table 3 Antimicrobial activity of cell-free supernatants, obtained from monocultures and co-cultures of probiotic strains of lactobacilli against conditionally pathogenic microorganisms isolated from lettuce leaves Escherichia coli supernatant Staphylococcus aureus Pseudomonas aeruginosa Serratia marcescens Monoculture 7412 20.00±0.00 24.00±0.00 17.67±0.58 23.67±0.58 A 18.67±0.58 20.67±0.58 17.33±0.58 21.00±1.00 A6 17.33±0.58 18.00±1.00 15.00±0.00 21.33±1.53 A22 18.00±0.00 20.67±0.58 18.33±0.58 22.33±1.15 S6 18.67±0.58 21.67±0.58 19.00±0.00 24.00±0.00 Shared culture 7412+А 18.67±0.58 23.50±0.50 17.50±0.50 23.67±0.58 7412+A6 17.67±0.58 24.83±0.29 17.00±1.00 23.67±0.58 7412+A22 19.00±1.00 21.67±0.58 17.33±0.58 24.67±0.58 7412+S6 21.67±0.58 26.00±0.00 19.67±0.58 23.67±0.58 A+A6 19.33±0.58 22.67±0.58 18.00±0.00 21.00±1.00 A+A22 16.33±0.58 18.83±0.29 14.00±1.00 26.00±1.00 A+S6 18.33±0.58 23.00±1.00 15.67±0.58 26.33±1.15 A6+A22 20.67±1.15 24.67±0.58 17.67±0.58 22.00±0.00 A6+S6 18.67±0.58 24.67±0.58 17.83±0.29 24.00±0.50 A22+S6 20.00±1.00 26.00±0.00 18.67±0.58 24.17±0.29 Note. 7412-Lacticaseibacillus casei; A-Lactiplantibacillus plantarum; A6, A22, S6-Lactobacillus bulgaricus. The highest antimicrobial activity was shown against Escherichia coli and Pseudomonas aeruginosa cell-free supernatant obtained after co-cultivation of Lactobacillus casei IMB 7412+Lactobacillus bulgaricus S6 (21.67±0.58 mm and 19.67±0.58 mm). The obtained values ​​exceeded activity of cell-free supernatants of the corresponding monocultures. Against Staphylococcus aureus, the largest zones of inhibition were observed for the supernatants of the combined Lactobacillus casei IMB 7412+Lactobacillus bulgaricus S6 and Lactobacillus bulgaricus cultures A22+Lactobacillus bulgaricus S6 (26.00±0.00 mm each). Instead, the highest antimicrobial activity was demonstrated against Serratia marcescens Supernatants of co-cultures Lactiplantibacillus plantarum A+Lactobacillus bulgaricus S6 (26.33±1.15 mm) and Lactiplantibacillus plantarum A+Lactobacillus bulgaricus A22 (26.00±0.00 mm). Thus, the results of the study indicate that for each tested conditional The pathogenic microorganism is characterized by a specific combination of probiotic strains Lactobacillus spp., co-cultivation of which ensures the production of a cell-free supernatant with maximum antimicrobial activity. The utility model can be used in the field of food biotechnology as a natural bioprotector of plant raw materials, in particular lettuce leaves, to reduce contamination of conditionally pathogenic microorganisms. Sources of information: 1. Bugyna, L., Sukhareva, O., Pallah, O., Yerem, K., Boyko, Ν., & Sukharev, S. (2022). Microelement composition of basic consumption products in the Transcarpathian region, Ukraine. Carpathian Journal of Food Science & Technology, 14(2). https: / / doi.org / 10.34302 / crpjfst / 2022.14.2.15 2. Bugyna, L., Pallah, O., Rukavchuk, R., & Boyko, N. (2020). Analysis of the microbiome of leaf surfaces of natural plants of the Transcarpathian region. Scientific Reports of the National University of Life and Environmental Sciences of Ukraine, 16(4). https: / / doi.org / 10.31548 / dopovidi2020.04.003. 3. Harutyunyan, N., Kushugulova, Α., Hovhannisyan, N., & Pepoyan, A. (2022). One Health Probiotics as Biocontrol Agents: One Health Tomato Probiotics. Plants, 11(10), 1334. https: / / doi.org / 10.3390 / plants11101334. 4. Arena, M. P., Silvain, Α., Normanno, G., Grieco, F., Drider, D., Spano, G., & Fiocco, D. (2016). Use of Lactobacillus plantarum Strains as a Bio-Control Strategy against Food-Borne Pathogenic Microorganisms. Frontiers in Microbiology, 7. https: / / doi.org / 10.3389 / fmicb.2016.00464. 5. Tang, H., Huang, W., & Yao, Y.-F. (2023). The metabolites of lactic acid bacteria: classification, biosynthesis and modulation of gut microbiota. Microbial Cell, 10(3), 49-62. https: / / doi.org / 10.15698 / mic2023.03.792 6. Saidi, N., Horieh Saderi, Parviz Owlia, & Soleimani, M. (2023). Anti-biofilm potential of Lactobacillus casei and Lactobacillus rhamnosus cell-free supernatant extracts against Staphylococcus aureus. Advanced Biomedical Research, 12(1), 50-50. https: / / doi.org / 10.4103 / abr.abr_156_21. 7. Jeyanathan, Α., Ramalhete, R., Blunn, G., Gibbs, H., Pumilia, С Α., Teerin Meckmongkol, Lovejoy, J., & Coathup, M. J. (2021). Lactobacillus cell-free supernatant as a novel bioagent and biosurfactant against Pseudomonas aeruginosa in the prevention and treatment of orthopedic implant infection. Journal of Biomedical Materials Research Part В Applied Biomaterials, 109(10), 1634-1643. https: / / doi.org / 10.1002 / jbm.b.34821. 8. Vahedi-Shahandashti, R., Kasra-Kermanshahi, R., Shokouhfard, M., Ghadam, P., Feizabadi, M. M., & Teimourian, S. (2017). Antagonistic activities of some probiotic lactobacilli culture supernatant on Serratia marcescens swarming motility and antibiotic resistance. Iranian Journal of Microbiology, 9(6), 348-355. https: / / pubmed.ncbi.nlm.nih.gov / 29487733 / . 9. Patent 120295 C2 Ukraine, IPC A01N 25 / 00, C12R 1 / 38, C12R 1 / 385, C12N 1 / 20. Method of protection plants from the causative agent of bacterial diseases Pseudomonas syringae / Balko O.B., Balko O.I., Zelena L.B., Pasichnyk L.A., Avdeeva L.V.; patent owner: D.K. Zabolotny Institute of Microbiology and Virology NAS of Ukraine; application No. a 2017 10137; filed on 10 / 20 / 2017; published on 04 / 25 / 2019, Bulletin No. 8. 10. Patent 82921 U Ukraine, published 27.08.2013, IPC A01N 63 / 00. Method of protecting plants from "Blackleg" disease using lactobacilli and erwinia autolysate / Sergeyeva Zh.Yu., Krylova K.D., Limanska N.V., Vasilyeva N.Yu., Ivanytsia V.O., Tovkach F.I., Basyul O.V., Korotaeva N.V.; patent owner: Odessa National University named after I.I. Mechnikov; application number u201300181; declared on 03.01.2013; published on 27.08.2013, Bulletin No. 16. 11. US Patent 10,588,320 B2, published 03 / 17 / 2020, IPC A01N 63 / 02, A01N 63 / 04, C05F 17 / 00. Cell-free supernatant composition of microbial culture for agricultural use / Bywater-Ekegard M, Fitzsimmons Α.; patent owner: Concentric AG Corporation (US); application No. 14 / 849,485; filed 09.09.2015; published 17.03.2020.

Claims

1. Method for obtaining cell-free supernatants with increased antimicrobial activity by co-cultivation of probiotic strains of lactobacilli, including cultivation of probiotic strains of lactobacilli in a liquid nutrient medium with with subsequent separation of the cell mass, co-cultivation is carried out at least two probiotic strains of Lactobacillus spp. in sterile MRS- broth at a temperature of 37 C for 24 hours, with 10 ml of medium inoculate 50 μl of suspensions of each strain at a concentration of 108 CFU / ml, after which The culture fluid is centrifuged for 15 min at 2500 g, the resulting fluid filtered through a membrane filter with a pore size of 0.22 μm.

2. The method according to claim 1, characterized in that the co-cultivation is carried out with using combinations of probiotic strains of Lactobacillus spp. selected from the group: Lacticaseibacillus casei IMB 7412 + Lactobacillus bulgaricus S6, Lactobacillus bulgaricus A22 + Lactobacillus bulgaricus S6, Lactiplantibacillus plantarum A + Lactobacillus bulgaricus S6, Lactiplantibacillus plantarum A + Lactobacillus bulgaricus A22.